Search research articles
Contact Us
Filters
Showing results (61-70 of 198) with videos related to
Page
of 20
Sort By:
JGH Open : an Open Access Journal of Gastroenterology and Hepatology
|
October 24, 2025
Prediction of Hepatocellular Carcinoma After Direct-Acting Antiviral Therapy Using Agile 3+ and End-of-Treatment Alpha-Fetoprotein Levels in Patients With Hepatitis C
Akifumi Kuwano, Masayoshi Yada, Kosuke Tanaka, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology
|
October 11, 2021
[A case of pembrolizumab-induced sclerosing cholangitis that was responsive to high-dose steroid therapy]
Shigehiro Nagasawa, Masayuki Miyazaki, Yusuke Morita, et al.
Journal of General and Family Medicine
|
November 6, 2025
How to promote female medical leaders? Insights and solutions from the JACRA Chief Resident Meeting
Masumi Ogushi, Kazuya Nagasaki, Toshinori Nishizawa, et al.
Internal Medicine (Tokyo, Japan)
|
March 28, 2012
Gefitinib for a poor performance status patient with squamous cell carcinoma of the lung harboring EGFR mutation
Kosuke Tanaka, Akito Hata, Yoko Kida, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
May 3, 2025
Tumor-infiltrating CD8<sup>+</sup> T-cell numbers and serum C-reactive protein levels as a prognostic biomarker in hepatocellular carcinoma patients receiving atezolizumab plus bevacizumab
Akifumi Kuwano, Masayoshi Yada, Kosuke Tanaka, et al.
Molecular and Clinical Oncology
|
January 24, 2022
Therapeutic efficacy of lenvatinib for hepatocellular carcinoma with iso-high intensity in the hepatobiliary phase of Gd-EOB-DTPA-MRI
Akifumi Kuwano, Kosuke Tanaka, Masayoshi Yada, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology
|
August 9, 2022
[A case of multiple osteonecrosis caused by acute-on-chronic pancreatitis]
Yusuke Morita, Akifumi Kuwano, Shigehiro Nagasawa, et al.
Anticancer Research
|
September 26, 2025
Cost-effectiveness Analysis of Atezolizumab Plus Bevacizumab <i>Versus</i> Lenvatinib in Intermediate-stage Hepatocellular Carcinoma: A Real-world Retrospective Study
Akifumi Kuwano, Masayoshi Yada, Kosuke Tanaka, et al.
In Vivo (Athens, Greece)
|
June 27, 2024
Similar Efficacy Between Atezolizumab Plus Bevacizumab <i>Versus</i> Hepatic Arterial Infusion Chemotherapy For Unresectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Retrospective Cohort Study
Akifumi Kuwano, Masayoshi Yada, Kosuke Tanaka, et al.
Experimental and Therapeutic Medicine
|
August 24, 2023
FIB‑4 index and serum α‑fetoprotein are useful predictors of hepatocellular carcinoma occurrence in hepatitis B patients with nucleos(t)ide analogs therapy
Akifumi Kuwano, Masayuki Miyazaki, Masayoshi Yada, et al.
Page
of 20
Search research articles
Search
Showing results (61-70 of 198) with videos related to
Sort By:
Page
of 20
JGH Open : an Open Access Journal of Gastroenterology and Hepatology
|
October 24, 2025
Prediction of Hepatocellular Carcinoma After Direct-Acting Antiviral Therapy Using Agile 3+ and End-of-Treatment Alpha-Fetoprotein Levels in Patients With Hepatitis C
Akifumi Kuwano, Masayoshi Yada, Kosuke Tanaka, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology
|
October 11, 2021
[A case of pembrolizumab-induced sclerosing cholangitis that was responsive to high-dose steroid therapy]
Shigehiro Nagasawa, Masayuki Miyazaki, Yusuke Morita, et al.
Journal of General and Family Medicine
|
November 6, 2025
How to promote female medical leaders? Insights and solutions from the JACRA Chief Resident Meeting
Masumi Ogushi, Kazuya Nagasaki, Toshinori Nishizawa, et al.
Internal Medicine (Tokyo, Japan)
|
March 28, 2012
Gefitinib for a poor performance status patient with squamous cell carcinoma of the lung harboring EGFR mutation
Kosuke Tanaka, Akito Hata, Yoko Kida, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
May 3, 2025
Tumor-infiltrating CD8<sup>+</sup> T-cell numbers and serum C-reactive protein levels as a prognostic biomarker in hepatocellular carcinoma patients receiving atezolizumab plus bevacizumab
Akifumi Kuwano, Masayoshi Yada, Kosuke Tanaka, et al.
Molecular and Clinical Oncology
|
January 24, 2022
Therapeutic efficacy of lenvatinib for hepatocellular carcinoma with iso-high intensity in the hepatobiliary phase of Gd-EOB-DTPA-MRI
Akifumi Kuwano, Kosuke Tanaka, Masayoshi Yada, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology
|
August 9, 2022
[A case of multiple osteonecrosis caused by acute-on-chronic pancreatitis]
Yusuke Morita, Akifumi Kuwano, Shigehiro Nagasawa, et al.
Anticancer Research
|
September 26, 2025
Cost-effectiveness Analysis of Atezolizumab Plus Bevacizumab <i>Versus</i> Lenvatinib in Intermediate-stage Hepatocellular Carcinoma: A Real-world Retrospective Study
Akifumi Kuwano, Masayoshi Yada, Kosuke Tanaka, et al.
In Vivo (Athens, Greece)
|
June 27, 2024
Similar Efficacy Between Atezolizumab Plus Bevacizumab <i>Versus</i> Hepatic Arterial Infusion Chemotherapy For Unresectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Retrospective Cohort Study
Akifumi Kuwano, Masayoshi Yada, Kosuke Tanaka, et al.
Experimental and Therapeutic Medicine
|
August 24, 2023
FIB‑4 index and serum α‑fetoprotein are useful predictors of hepatocellular carcinoma occurrence in hepatitis B patients with nucleos(t)ide analogs therapy
Akifumi Kuwano, Masayuki Miyazaki, Masayoshi Yada, et al.
Page
of 20